This site is intended for healthcare professionals only

NICE to have 'crucial role' in value-based pricing

Written by: | Published:

NICE will have a 'crucial role' in the value-based pricing of medicines from 2014, the DH has confirmed.

Its role will include undertaking an assessment of the costs and benefits of different medicines, drawing on its world-leading expertise and it will be responsible for the full value assessment of medicines under the future system.

Under the new scheme, NICE will be given a broader scope to assess a medicine's benefits and costs in a bid to ensure the price the NHS pays for new medicines is linked to their value to patients.

Value-based pricing will replace the Pharmaceutical Price Regulation Scheme (PPRS) in January 2014.

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.

Comments

Name
 
Email
 
Comments
 

Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code
 

Most read articles from Practice Nursing Journal

Practice Nursing Journal latest issue and most read articles.

Click here to read a selection of free to access articles from Practice Nursing Journal

Newsletter

Sign up to the newsletter

About

Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.

Newsletter

Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.

Archive

Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team

Authors

Find out how to contribute to Independent Nurse here.